no debt? you're kidding right? what about the debt to the long term shareholders (like me) who have been raped again and again with reverse splits? Sell it somewhere else, Junior.
Recurrent Chest Wall is not as prevalent as more typical breast cancer. It is women who have had breast cancer and a mastectomy and then the cancer spreads to the chest wall. They also have tried all available treatments, so TDox has become the last resort and it has worked for some. That should be enough for breakthrough approval.
Actually I was referring to the DIGNITY STUDY .. With P2 confirming P1,, and no other treatment available ,, Either the FDA or CLSN should be considering the BTD application..
As to the HEAT STUDY,, the section of the trial treating 5 to 7cm HCC,, combined with the safety profile of TDOX,, which allows for multiple treatments,, which could turn HCC into a chronic disease should also be considered for BTD...
The FDA's new "breakthrough" product designation allows new drugs to win approval after just a single round of testing, instead of the usual three. -----"A breakthrough drug is one that may offer important new benefits for patients with serious or life-threatening disease who are especially in need of new safe and effective treatments," said Janet Woodcock, director of FDA's Center for Drug Evaluation and Research.
And,, if the agency is seeing promise in trial results,, they can ask the trial sponsor to apply for BTD..
$10 in a few months would be music to my ears. I think that is doable. It's really only $2+ pre split
first wall is 3.55 and i think we can reach high 3's or even 4 by the end of the day
EXEL at 800+ million market cap is selling 4.21 per share, or so. That is the difference between low float stocks and large floats. Or Outstanding shares to be precise.
Grab as much as you can. With a market cap of only $50M this can be a 10 bagger before FDA approval is close.
And still have a reasonable market cap. Looking forward to adding more at the 50 cent level pre reverse split.